Renal N-oxidation of trimethylamine in the chicken during tubular excretion
- PMID: 13980
Renal N-oxidation of trimethylamine in the chicken during tubular excretion
Abstract
The Sperber technique of infusion into the renal portal circulation in chickens was used to investigate in vivo the renal tubular transport and renal metabolism of trimethylamine (TMA). When 14C-TMA was infused at a rate of 1 x 10(-9) mol/min the transport efficiency (TE), that is, the tubular excretion of the 14C-label relative to excretion of simultaneously infused paminohippuric acid, was 0.70. Progressive addition of unlabeled TMA up to infusion rates of 1 x 10(-5) mol/min produced a progressive fall in the TE of the 14C-label. Identification of the 14C-label excreted in the urine revealed that approximately 85% of the infused 14C-TMA was excreted by the infused kidney as a single metabolite over the entire range of infusions. By use of the techniques of low-voltage electrophoresis, high-voltage electrophoretic mobility-pH profile, and gas chromatography/mass spectrometry, the renal metabolite was found to be identical with standard 14C-trimethylamine oxide (TMAO). At a TMA infusion rate of 1.5 x 10(-6) mol/kg/min reaching the infused kidney, the rate at which TMAO was formed and excreted by the kidney was 0.12 x 10(-6) mol per g of kidney per min. When 14C-TMAO was infused into chickens its TE was 0.11, which was not evidence for active excretory transport. Infused TMA was almost entirely metabolized in vivo to its N-oxide, TMAO, which then entered the urine. The renal tubular excretion of 14C during infusion of 14C-TMA was inhibited by the cationic blocker of transport, quinine, and by the anionic blocker of transport, probenecid.
Similar articles
-
Excretion and metabolism of nicotinic acid by the avian kidney.J Pharmacol Exp Ther. 1988 Mar;244(3):797-801. J Pharmacol Exp Ther. 1988. PMID: 3252032
-
The metabolism and active excretion of the hypoxanthine by the renal tubules in the chicken.J Pharmacol Exp Ther. 1978 Nov;207(2):574-83. J Pharmacol Exp Ther. 1978. PMID: 712639
-
The biphasic effect of organic cations on the excretion of other organic cations.J Pharmacol Exp Ther. 1976 Oct;199(1):32-40. J Pharmacol Exp Ther. 1976. PMID: 989775
-
Analysis, biology and significance of dimethylamine, trimethylamine and trimethylamine N-oxide in humans and in the marine ecosystem.J Chromatogr B Analyt Technol Biomed Life Sci. 2025 May 15;1258:124602. doi: 10.1016/j.jchromb.2025.124602. Epub 2025 Apr 14. J Chromatogr B Analyt Technol Biomed Life Sci. 2025. PMID: 40252559 Review.
-
Microbiology Meets Big Data: The Case of Gut Microbiota-Derived Trimethylamine.Annu Rev Microbiol. 2015;69:305-21. doi: 10.1146/annurev-micro-091014-104422. Epub 2015 Aug 13. Annu Rev Microbiol. 2015. PMID: 26274026 Review.
Cited by
-
Trimethylamine N-Oxide as a Novel Therapeutic Target in CKD.J Am Soc Nephrol. 2016 Jan;27(1):8-10. doi: 10.1681/ASN.2015050576. Epub 2015 Jul 30. J Am Soc Nephrol. 2016. PMID: 26229138 Free PMC article. No abstract available.
-
Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.Sci Rep. 2017 Jul 10;7(1):4939. doi: 10.1038/s41598-017-04949-2. Sci Rep. 2017. PMID: 28694431 Free PMC article.
-
Microbiome, trimethylamine N-oxide, and cardiometabolic disease.Transl Res. 2017 Jan;179:108-115. doi: 10.1016/j.trsl.2016.07.007. Epub 2016 Jul 18. Transl Res. 2017. PMID: 27490453 Free PMC article. Review.
-
Dietary metabolism, the gut microbiome, and heart failure.Nat Rev Cardiol. 2019 Mar;16(3):137-154. doi: 10.1038/s41569-018-0108-7. Nat Rev Cardiol. 2019. PMID: 30410105 Free PMC article. Review.
-
Loop Diuretics Inhibit Renal Excretion of Trimethylamine N-Oxide.JACC Basic Transl Sci. 2021 Jan 27;6(2):103-115. doi: 10.1016/j.jacbts.2020.11.010. eCollection 2021 Feb. JACC Basic Transl Sci. 2021. PMID: 33665512 Free PMC article.